ArthritisDigest2013

Bone loss drug may help stave off endometrial cancer

Women who use bisphosphonates – drugs that treat osteoporosis and other bone conditions – seem to have about half the risk of developing endometrial cancer as women who do not use the drugs, according to findings in Cancer.

Previous research has found that bisphosphonates reduce the likelihood of some forms of cancer; the new study suggests that endometrial cancer, which arises in the lining of the uterus, can be added to the list. Continue reading

New drug tanezumab shows promise for some people with osteoarthritis… but it’s early days

dewThe safety and efficacy of tanezumab – a drug for people with osteoarthritis – has been reported in the Journal of Rheumatology.

US studies compared the performance of the drug, administered intravenously, to naproxen in the treatment of hip or knee osteoarthritis.
The two studies involved 828 and 840 patients, who were given 5mg and 10mg doses of tanezumab compared to placebo and 500mg twice-daily administration of naproxen. Continue reading